Ovid Therapeutics Inc (OVID) Price Targets From Analysts
Use the tables below to see what analysts covering Ovid Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $7 | $4 | $4.88 | $3.76 | 29.79% |
The Trend in the Analyst Price Target
OVID's average price target has moved down $9.95 over the prior 43 weeks.
Over the past 15 months, OVID's average upside potential has been 86.74%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-24 | 4 | 7 | 4 | 4.88 | 3.740 | 30.48% |
| 2021-07-17 | 4 | 7 | 4 | 4.88 | 3.700 | 31.89% |
| 2021-07-10 | 4 | 7 | 4 | 4.88 | 3.940 | 23.86% |
| 2021-07-03 | 4 | 7 | 4 | 4.88 | 4.040 | 20.79% |
| 2021-06-24 | 4 | 7 | 4 | 4.88 | 4.290 | 13.75% |
| 2021-06-13 | 4 | 8 | 4 | 5.88 | 4.490 | 30.96% |
| 2021-06-05 | 4 | 8 | 4 | 5.88 | 4.380 | 34.25% |
| 2021-05-03 | 4 | 8 | 4 | 6.00 | 3.730 | 60.86% |
| 2021-04-25 | 4 | 8 | 4 | 6.00 | 3.670 | 63.49% |
| 2021-04-17 | 4 | 8 | 5 | 6.25 | 3.780 | 65.34% |
| 2021-04-10 | 4 | 8 | 5 | 6.25 | 3.690 | 69.38% |
| 2021-04-03 | 4 | 8 | 5 | 6.25 | 4.070 | 53.56% |
| 2021-03-20 | 4 | 8 | 5 | 6.25 | 4.470 | 39.82% |
| 2021-03-02 | 4 | 8 | 4 | 6.00 | 2.960 | 102.7% |
| 2021-02-27 | 4 | 8 | 4 | 6.00 | 2.950 | 103.39% |
| 2021-02-20 | 4 | 8 | 4 | 6.00 | 3.470 | 72.91% |
| 2021-02-13 | 4 | 8 | 4 | 6.00 | 3.420 | 75.44% |
| 2021-02-06 | 4 | 8 | 4 | 6.00 | 3.190 | 88.09% |
| 2021-01-30 | 4 | 8 | 4 | 6.00 | 2.810 | 113.52% |
| 2021-01-23 | 4 | 8 | 4 | 6.00 | 2.710 | 121.4% |
| 2021-01-07 | 4 | 8 | 4 | 6.00 | 2.500 | 140% |
| 2020-12-30 | 4 | 8 | 4 | 6.00 | 2.380 | 152.1% |
| 2020-12-26 | 4 | 8 | 4 | 6.00 | 2.610 | 129.89% |
| 2020-12-19 | 4 | 8 | 4 | 6.00 | 2.650 | 126.42% |
| 2020-12-10 | 4 | 8 | 4 | 6.00 | 2.620 | 129.01% |
| 2020-12-07 | 4 | 8 | 4 | 6.00 | 2.580 | 132.56% |
| 2020-11-13 | 6 | 21 | 10 | 14.67 | 6.040 | 142.88% |
| 2020-09-29 | 6 | 21 | 10 | 14.83 | 5.980 | 147.99% |
| 2020-09-23 | 6 | 21 | 10 | 14.19 | 5.800 | 144.66% |
| 2020-08-25 | 6 | 21 | 10 | 14.19 | 6.335 | 123.99% |
| 2020-08-10 | 6 | 21 | 9 | 13.52 | 7.140 | 89.36% |
| 2020-07-31 | 6 | 21 | 9 | 12.96 | 6.450 | 100.93% |
| 2020-07-21 | 5 | 21 | 9 | 13.60 | NA | NA% |
| 2020-07-13 | 5 | 21 | 9 | 13.60 | NA | NA% |
| 2020-07-05 | 5 | 20 | 8 | 13.00 | NA | NA% |
| 2020-06-17 | 6 | 20 | 8 | 12.43 | NA | NA% |
| 2020-05-14 | 6 | 20 | 7 | 11.43 | NA | NA% |
OVID Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.64 | 2 | 1 | 4 | 0 | 0 | 7 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Ovid Therapeutics Inc's average analyst price target is greater than 7.68% of all US stocks.
- The variance in analysts' estimates of OVID is less than 15.24% of stocks in the small market cap category.
- The upside potential (average analyst target price relative to current price) of OVID is higher than 18.97% of Pharmaceutical Products stocks.
- OVID has a greater number of analysts covering the stock than 33.95% of Pharmaceutical Products stocks.
Stocks similar to Ovid Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RUBY, KIN and OGN.
Is OVID a Buy, Hold or Sell? See the POWR Ratings now!